CSRxP Commends Administration for Commitment to DTC Advertising Rule

Applauds HHS For Appealing Ruling Against List Price Transparency Measure   For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for

08-21-2019 Read More

Second Opinion: GAO Undermines Common Refrain in Big Pharma’s Blame Game

Analysis Finds PBMs Pass On Over 99 Percent of Rebates, Used to Keep Premiums Down A new report from the Government Accountability Office (GAO) undermines a common refrain in Big Pharma’s blame

08-16-2019 Read More

Q2 Earnings: Big Pharma Keeps Living the Good Life While Evading Accountability

Q2 Earnings: Big Pharma Keeps Living the Good Life While Evading Accountability Drug Makers Sweep Profit Forecasts as Industry Continues to Price-Gouge American Patients   For Immediate Release

07-31-2019 Read More

Big Pharma Earnings Watch: Amgen, Eli Lilly, Merck and Pfizer

Four More Rx Giants Complete the Sweep, Beat Q2 Earnings Forecasts After Hiking Prices   Over the past week, CSRxP has been tracking Q2 earnings for the biggest prescription drug manufacturers

07-31-2019 Read More

Big Pharma Earnings Watch: AbbVie and Sanofi

Brand Name Drug Makers Continue to Surpass Q2 Forecasts After Hiking Prices   Pharmaceutical giants AbbVie and Sanofi kept the good times rolling for Big Pharma on Friday and Monday, with both

07-30-2019 Read More

Big Pharma Earnings Watch: Bristol-Myers Squibb, AstraZeneca, Roche

Three More Drug Makers Top Earnings Expectations in Q2   Today three more price-gouging Big Pharma companies reported better-than-expected earnings in Q2 and raised forecasts for the rest of

07-29-2019 Read More

CSRxP: Senate Finance Takes Positive Steps to Hold Big Pharma Accountable, Lower Drug Prices

Commends Bipartisan Collaboration on Several Market-Based Solutions, Cautions Committee Leaders Against Revival of Misguided Rebate Rule     For Immediate Release Contact: Jon Conradi

07-25-2019 Read More

Big Pharma Earnings Watch: GlaxoSmithKline

Big Pharma Giants Now Three for Three Besting Forecasts After Hiking Prices   More Big Pharma giants are reporting earnings this week for the second quarter of 2019. Today GlaxoSmithKline (GSK)

07-24-2019 Read More

CSRxP Applauds Grassley, Wyden for Moving Ahead on Drug Pricing Package

Looks Forward to Working With Senate Finance Members to Hold Big Pharma Accountable For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected]   Washington, D.C. – The Campaign

07-23-2019 Read More

Sign-up for updates

  • This field is for validation purposes and should be left unchanged.